Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer
Open Access
- 1 December 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 54 (12) , 2042-2048
Abstract
Background: Increased thrombin generation is associated with an increased risk of recurrent venous thromboembolism. We investigated the relation between endogenous thrombin potential (ETP) and risk of recurrent venous thromboembolism and evaluated whether prediction of recurrence can be improved by a combined analysis of ETP and D-dimer. Methods: We followed 861 patients with first spontaneous venous thromboembolism and determined ETP and D-dimer after discontinuation of anticoagulation. Patients with natural inhibitor deficiency, lupus anticoagulant, or cancer were excluded. The study endpoint was symptomatic recurrent venous thromboembolism. Results: One hundred thirty patients (15.1%) had recurrence. High ETP (≥100%) conferred a 1.6-fold increased risk of recurrence (95% CI 1.1–2.3) after adjustment for age, sex, factor V Leiden, factor II G20210A, and duration of anticoagulation. After adjustment for D-dimer, risk of recurrence remained significantly higher among patients with high ETP [hazard ratio 1.6 (95% CI 1.01–2.4)]. After adjustment for ETP, high D-dimer (≥0.5 mg/L) conferred a 1.8-fold (95% CI 1.1–2.8) increased risk of recurrence. Compared with patients with low ETP and low D-dimer, risk of recurrence was 2.8-fold (95% CI 1.5–5.3) higher among patients with both high ETP and high D-dimer after adjustment for potential confounders. Conclusions: ETP and D-dimer are independent predictors of recurrent venous thromboembolism. Assessing risk of recurrence can be optimized by combining these indicators of thrombin generation.Keywords
This publication has 16 references indexed in Scilit:
- The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous ThromboembolismAnnals of Internal Medicine, 2007
- Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrenceBritish Journal of Haematology, 2007
- Incidence and mortality of venous thrombosis: a population‐based studyJournal of Thrombosis and Haemostasis, 2007
- d-Dimer Testing to Determine the Duration of Anticoagulation TherapyNew England Journal of Medicine, 2006
- Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin GenerationJAMA, 2006
- New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolismThrombosis and Haemostasis, 2006
- Thrombin generation profiles in deep venous thrombosisJournal of Thrombosis and Haemostasis, 2005
- Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic EventsJAMA, 2005
- Hemorrhagic Complications of Anticoagulant TreatmentChest, 2004
- D-Dimer Levels and Risk of Recurrent Venous ThromboembolismJAMA, 2003